NCT02009800View on ClinicalTrials.gov

ICI-VPH: Impact of HPV Immunisation Schedules Against HPV

PHASE3CompletedINTERVENTIONAL
Enrollment

3,364

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Human Papillomavirus Infections
Interventions
BIOLOGICAL

Quadrivalent HPV vaccine

One dose of Gardasil administered in the intervention group

Trial Locations (2)

H2W 1T8

Centre Hospitalier Uiversitaire de Montréal, Montreal

G1R 2J6

Centre Hospitalier Universitaire de Québec, CHU de Québec, Québec

All Listed Sponsors
collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

collaborator

Ministere de la Sante et des Services Sociaux

OTHER

collaborator

Institut National en Santé Publique du Québec

OTHER

lead

CHU de Quebec-Universite Laval

OTHER

NCT02009800 - ICI-VPH: Impact of HPV Immunisation Schedules Against HPV | Biotech Hunter | Biotech Hunter